Hit Back at Crohn’s Disease
Crohn’s disease has been beating up on you long enough. Now it’s your turn to hit back.
Only STELARA® starts with a one-time intravenous (IV) infusion to help reduce symptoms, followed by subcutaneous maintenance injections to help keep the disease under control.
STELARA® is also the only FDA-approved medicine that targets two different proteins (IL-12 and IL-23) that are thought to be associated with gastrointestinal inflammation in Crohn's disease.
Over the last 7 years, more than 135,000 patients have been prescribed STELARA® for the treatment of other autoimmune conditions.